BioTime brought in $4 million through a second tranche of its private placement. It said if the warrants are exercised by Oct. 31, 2009, it could bring in a total of $24 million from the private placement.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.